Pyxis Oncology, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Pyxis Oncology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2023.
  • Pyxis Oncology, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 60.7M shares, a 46.9% increase year-over-year.
  • Pyxis Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 39.9M shares, a 20.8% increase from 2022.
  • Pyxis Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 33M shares, a 289% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 39.9M +6.87M +20.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 33M +24.5M +289% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 8.49M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.